Company Badge
USPTO Data Jan 1 1976 - Nov 10 2026
4 Patents
#40 in Exton, PA
#2,218 in Pennsylvania
#60,778 in US
Melior Discovery, Inc.
Forward Citations = 0
9 inventors:
Exton, PA, United States of America
Melior Discovery, Inc.
Calculating rank
% Expired Patents = 50.0
CIPO Patents = 3
EPO Patents = 1
Trademarks = 4
Forward Citations = 0
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Andrew G Reaume (4 out of 21 patents)
Michael S Saporito (4 out of 18 patents)
John Ciallella (2 out of 6 patents)
4. John Gruner (2 out of 6 patents)
5. Heather Hain (2 out of 2 patents)
6. Andrew G Reaume (0 patent)
7. Michael S Saporito (0 patent)
8. John Ciallella (0 patent)
9. John Gruner (0 patent)
4 patents:
Company Overview
Melior Discovery, Inc. is a biopharmaceutical company focused on developing novel therapeutics for metabolic diseases and inflammatory conditions. With a unique approach to drug discovery, Melior utilizes its proprietary theraTRACE platform to identify and optimize drug candidates with high efficacy and minimal side effects. The company has a strong pipeline of compounds in various stages of development and a track record of successful partnerships with pharmaceutical companies.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Melior Discovery, Inc.. Retrieved from https://idiyas.com/company/melior-discovery
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]